Elsawy, M. 2022. Chimeric antigen receptor T-cell therapy for relapsed and refractory large B-cell lymphoma: A Canadian perspective. Canadian Hematology Today. 1, 2 (Jul. 2022), 26–33. DOI:https://doi.org/10.58931/cht.2022.1214.